3004.90.92.16/Imatinib Mesylate 400mg Tablets/Mexico

Imatinib Mesylate 400mg Tablets from Mexico

Imatinib mesylate tablets are an antineoplastic medicament used primarily for treating chronic myeloid leukemia by inhibiting tyrosine kinase activity. They are put up in measured doses of 400mg per tablet in retail packaging, qualifying under HTS 3004.90.92.16 as an unmixed antineoplastic product for therapeutic use.

Duty Rate — Mexico → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Verify FDA approval and provide certificates of analysis confirming active ingredient purity to avoid detention at customs

• Ensure labeling complies with 21 CFR 201 for prescription drugs, including lot numbers and expiry dates

Imatinib Mesylate 400mg Tablets from Mexico — Import Duty Rate | HTS 3004.90.92.16